Caricamento...
Adherence to lenalidomide in older adults with newly-diagnosed multiple myeloma
INTRODUCTION: One of the most common orally administered anti-myeloma agent, lenalidomide, has significantly improved outcomes in multiple myeloma, including in older patients. However, despite its utilization and cost, the rates and factors related to adherence to lenalidomide in older adults with...
Salvato in:
| Pubblicato in: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564009/ https://ncbi.nlm.nih.gov/pubmed/31843543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.09.618 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|